Exubera - Inhaled Insulin for Type 1 and Type 2 Diabetes
Key Data:
Drug (Brand/Generic)
Exubera
Company/Licensee
Aventis and Pfizer
Therapy Class
Rapid-acting insulin
Product Description
Inhaled insulin preparation
Current Indication
Insulin-treated diabetes
Market Sector
Diabetes
Development Status
Product withdrawn in October 2007
